Vanguard Capital Management’s Cocrystal Pharma COCP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$412K Hold
358,228
– – ﹤0.01% 3700
2026
Q2
$376K Buy
358,228
+118,257
+49% +$146K ﹤0.01% 3754
2026
Q1
$242K Buy
+239,971
New +$248K ﹤0.01% 3776

Other funds holding COCP

Vanguard Capital Management's COCP Position: Q3 2026 in Review

Vanguard Capital Management held its Cocrystal Pharma (COCP) position steady in Q3 2026 at 358,228 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #3700.

Vanguard Capital Management first reported a position in COCP in Q1 2026 and has held it in 3 quarters since. 25 funds tracked by Wall St. Rank hold COCP as of Q3 2026.

  • Vanguard Capital Management held 358,228 shares of Cocrystal Pharma worth $412K as of Q3 2026.
  • Vanguard Capital Management left its Cocrystal Pharma share count unchanged in Q3 2026.
  • Cocrystal Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3700 holding.
  • Vanguard Capital Management first reported a position in Cocrystal Pharma in Q1 2026 and has held it in 3 quarters since.
  • 25 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.